Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Program Committee
-
Nancy A. Dreyer, PhD, MPH, FISPE • Chief Scientific Officer and Senior Vice President
IQVIA, United States -
Steven A. Anderson, PhD • Director, Office of Biostatistics and Epidemiology, CBER
FDA, United States -
Dorothee B Bartels, PhD, MSc • Head of Global Real World Evidence and Digital Science
UCB, Germany -
Brian Bradbury, PhD, MA • Vice President, Center for Observational Research
Amgen, United States -
Paul M. Coplan, DrSc, MBA, MSc, FISPE • VP, Medical Device Epidemiology & Real-World Data Analytics
Johnson & Johnson, United States -
Marni Hall, PhD, MPH • Vice President, Clinical Evidence
IQVIA, United States -
James Harnett, PharmD, MS • Executive Director, Health Economics and Outcomes Research
Regeneron Pharmaceuticals, Inc. , United States -
Jingyu (Julia) Luan, PhD • Global Regulatory Affairs Director, BioPharmaceuticals R&D, CVRM
AstraZeneca, United States -
David Martin, MD, MPH • Vice President, Clinical Safety and Risk Management
Moderna, United States -
Robert Reynolds, DrSc, FISPE • Vice President, Epidemiology & Patient-Centered Outcomes
GlaxoSmithKline, United States -
Debra Schaumberg, DrSc, MPH • Vice President, Epidemiology & Head Strategic and Scientific Affairs
Evidera | PPD, United States -
Mark Stewart, PhD • Vice President, Science Policy
Friends of Cancer Research, United States
